Showing results (2911-2920 of 4,070) with videos related to
Sort By:
Pageof 407
Plos Medicine|March 14, 2024
Antimicrobial resistance prevalence in bloodstream infection in 29 European countries by age and sex: An observational studyNaomi R Waterlow, Ben S Cooper, Julie V Robotham, et al.Plos Medicine|March 19, 2024
Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trialZoe Moodie, Erica Andersen-Nissen, Nicole Grunenberg, et al.Plos Medicine|February 15, 2024
Health outcomes after myocardial infarction: A population study of 56 million people in EnglandMarlous Hall, Lesley Smith, Jianhua Wu, et al.Plos Medicine|February 29, 2024
Diagnosis and management of endometrial hyperplasia: A UK national audit of adherence to national guidance 2012-2020Ian Henderson, Naomi Black, Hajra Khattak, et al.Plos Medicine|February 13, 2024
Food additive emulsifiers and cancer risk: Results from the French prospective NutriNet-Santé cohortLaury Sellem, Bernard Srour, Guillaume Javaux, et al.Plos Medicine|February 13, 2024
Correction: Migraine and risk of premature myocardial infarction and stroke among men and women: A Danish population-based cohort studyCecilia Hvitfeldt Fuglsang, Lars Pedersen, Morten Schmidt, et al.Plos Medicine|April 4, 2024
Climate change: A driver of increasing vector-borne disease transmission in non-endemic areasShlomit PazPlos Medicine|April 4, 2024
Long-term outcomes of hospitalized patients with SARS-CoV-2/COVID-19 with and without neurological involvement: 3-year follow-up assessmentAnna Eligulashvili, Moshe Gordon, Jimmy S Lee, et al.Plos Medicine|February 20, 2024
Risk of long COVID and associated symptoms after acute SARS-COV-2 infection in ethnic minorities: A nationwide register-linked cohort study in DenmarkGeorge Frederick Mkoma, Charles Agyemang, Thomas Benfield, et al.Plos Medicine|February 20, 2024
Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trialFred C Semitala, Jillian L Kadota, Allan Musinguzi, et al.Pageof 407